{"date":"2025-09-09","count":4,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-3716-2025-09-09-1653-3akeyq","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-09-09","time":"16:53:14","subject":"代子公司「中化裕民健康事業股份有限公司」公告董事會選任董事長。","clause":"第6款","fact_date":"2025-09-09","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-09-09 16:53，「代子公司「中化裕民健康事業股份有限公司」公告董事會選任董事長。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-09-09-1652-1fgo4e2","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-09-09","time":"16:52:38","subject":"代子公司「中化裕民健康事業股份有限公司」公告新任董監事成員。","clause":"第6款","fact_date":"2025-09-09","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-09-09 16:52，「代子公司「中化裕民健康事業股份有限公司」公告新任董監事成員。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-09-09-1537-1qpw9vd","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-09-09","time":"15:37:27","subject":"代子公司高峰藥品材料股份有限公司公告股東臨時會決議通過解除董事競業禁止之限制。","clause":"第21款","fact_date":"2025-09-09","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-09-09 15:37，「代子公司高峰藥品材料股份有限公司公告股東臨時會決議通過解除董事競業禁止之限制。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-09-09-1536-1vv0jbz","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-09-09","time":"15:36:56","subject":"代子公司高峰藥品材料股份有限公司公告114年第1次股東臨時會重要決議","clause":"第18款","fact_date":"2025-09-09","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-09-09 15:36，「代子公司高峰藥品材料股份有限公司公告114年第1次股東臨時會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}